vs

Side-by-side financial comparison of Corning Inc. (GLW) and ICAHN ENTERPRISES L.P. (IEP). Click either name above to swap in a different company.

Corning Inc. is the larger business by last-quarter revenue ($4.1B vs $2.7B, roughly 1.5× ICAHN ENTERPRISES L.P.). Corning Inc. runs the higher net margin — 9.3% vs 0.0%, a 9.3% gap on every dollar of revenue. On growth, ICAHN ENTERPRISES L.P. posted the faster year-over-year revenue change (5.4% vs 0.0%). Corning Inc. produced more free cash flow last quarter ($188.0M vs $-496.0M). Over the past eight quarters, Corning Inc.'s revenue compounded faster (12.9% CAGR vs 4.5%).

Corning Incorporated is an American multinational technology company specializing in glass, ceramics, and related materials and technologies including advanced optics, primarily for industrial and scientific applications. Founded in 1851, the company was called Corning Glass Works for most of its history. Corning was known during the 20th century for its consumer product lines, such as including CorningWare and Visions Pyroceram-based cookware, Corelle Vitrelle tableware, and Pyrex glass bake...

Icahn Enterprises L.P. is an American publicly traded master limited partnership and conglomerate headquartered at Milton Tower in Sunny Isles Beach, Florida. The company has investments in various industries including energy, automotive, food packaging, metals, real estate and home fashion. The company is controlled by Carl Icahn, who owns 86 percent of it.

GLW vs IEP — Head-to-Head

Bigger by revenue
GLW
GLW
1.5× larger
GLW
$4.1B
$2.7B
IEP
Growing faster (revenue YoY)
IEP
IEP
+5.4% gap
IEP
5.4%
0.0%
GLW
Higher net margin
GLW
GLW
9.3% more per $
GLW
9.3%
0.0%
IEP
More free cash flow
GLW
GLW
$684.0M more FCF
GLW
$188.0M
$-496.0M
IEP
Faster 2-yr revenue CAGR
GLW
GLW
Annualised
GLW
12.9%
4.5%
IEP

Income Statement — Q1 FY2026 vs Q4 FY2025

Metric
GLW
GLW
IEP
IEP
Revenue
$4.1B
$2.7B
Net Profit
$387.0M
$1.0M
Gross Margin
36.9%
Operating Margin
15.4%
0.6%
Net Margin
9.3%
0.0%
Revenue YoY
0.0%
5.4%
Net Profit YoY
-60.0%
101.0%
EPS (diluted)
$0.43

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GLW
GLW
IEP
IEP
Q1 26
$4.1B
Q4 25
$4.2B
$2.7B
Q3 25
$4.1B
$2.7B
Q2 25
$3.9B
$2.4B
Q1 25
$3.5B
$1.9B
Q4 24
$3.5B
$2.6B
Q3 24
$3.4B
$2.8B
Q2 24
$3.3B
$2.2B
Net Profit
GLW
GLW
IEP
IEP
Q1 26
$387.0M
Q4 25
$540.0M
$1.0M
Q3 25
$430.0M
$287.0M
Q2 25
$469.0M
$-165.0M
Q1 25
$157.0M
$-422.0M
Q4 24
$310.0M
$-98.0M
Q3 24
$-117.0M
$22.0M
Q2 24
$104.0M
$-331.0M
Gross Margin
GLW
GLW
IEP
IEP
Q1 26
36.9%
Q4 25
35.5%
Q3 25
37.1%
Q2 25
36.0%
Q1 25
35.2%
Q4 24
34.2%
Q3 24
33.5%
Q2 24
29.2%
Operating Margin
GLW
GLW
IEP
IEP
Q1 26
15.4%
Q4 25
15.9%
0.6%
Q3 25
14.4%
19.7%
Q2 25
14.8%
-10.4%
Q1 25
12.9%
-35.0%
Q4 24
11.2%
-5.2%
Q3 24
8.9%
2.4%
Q2 24
5.7%
-21.9%
Net Margin
GLW
GLW
IEP
IEP
Q1 26
9.3%
Q4 25
12.8%
0.0%
Q3 25
10.5%
10.5%
Q2 25
12.1%
-7.0%
Q1 25
4.5%
-22.6%
Q4 24
8.9%
-3.8%
Q3 24
-3.5%
0.8%
Q2 24
3.2%
-15.0%
EPS (diluted)
GLW
GLW
IEP
IEP
Q1 26
$0.43
Q4 25
$0.61
Q3 25
$0.50
Q2 25
$0.54
Q1 25
$0.18
Q4 24
$0.36
Q3 24
$-0.14
Q2 24
$0.12

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GLW
GLW
IEP
IEP
Cash + ST InvestmentsLiquidity on hand
$1.8M
$1.4B
Total DebtLower is stronger
$7.7M
Stockholders' EquityBook value
$12.3M
Total Assets
$31.3M
$14.2B
Debt / EquityLower = less leverage
0.62×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GLW
GLW
IEP
IEP
Q1 26
$1.8M
Q4 25
$1.5B
$1.4B
Q3 25
$1.8B
Q2 25
$1.8B
Q1 25
$2.2B
Q4 24
$1.8B
$2.6B
Q3 24
$2.3B
Q2 24
$2.2B
Total Debt
GLW
GLW
IEP
IEP
Q1 26
$7.7M
Q4 25
$7.6B
Q3 25
$7.4B
Q2 25
$6.7B
Q1 25
$7.0B
Q4 24
$6.9B
Q3 24
$7.1B
Q2 24
$6.9B
Stockholders' Equity
GLW
GLW
IEP
IEP
Q1 26
$12.3M
Q4 25
$11.8B
Q3 25
$11.5B
Q2 25
$11.1B
Q1 25
$10.7B
Q4 24
$10.7B
Q3 24
$11.1B
Q2 24
$10.6B
Total Assets
GLW
GLW
IEP
IEP
Q1 26
$31.3M
Q4 25
$31.0B
$14.2B
Q3 25
$29.9B
$14.8B
Q2 25
$28.7B
$14.8B
Q1 25
$27.4B
$15.5B
Q4 24
$27.7B
$16.3B
Q3 24
$28.3B
$17.4B
Q2 24
$27.2B
$18.0B
Debt / Equity
GLW
GLW
IEP
IEP
Q1 26
0.62×
Q4 25
0.65×
Q3 25
0.64×
Q2 25
0.60×
Q1 25
0.65×
Q4 24
0.64×
Q3 24
0.64×
Q2 24
0.65×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GLW
GLW
IEP
IEP
Operating Cash FlowLast quarter
$362.0M
$-421.0M
Free Cash FlowOCF − Capex
$188.0M
$-496.0M
FCF MarginFCF / Revenue
4.5%
-18.4%
Capex IntensityCapex / Revenue
8.0%
2.8%
Cash ConversionOCF / Net Profit
0.94×
-421.00×
TTM Free Cash FlowTrailing 4 quarters
$1.7B
$-654.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GLW
GLW
IEP
IEP
Q1 26
$362.0M
Q4 25
$1.1B
$-421.0M
Q3 25
$784.0M
$15.0M
Q2 25
$708.0M
$275.0M
Q1 25
$151.0M
$-182.0M
Q4 24
$623.0M
$244.0M
Q3 24
$699.0M
$-54.0M
Q2 24
$521.0M
$893.0M
Free Cash Flow
GLW
GLW
IEP
IEP
Q1 26
$188.0M
Q4 25
$620.0M
$-496.0M
Q3 25
$450.0M
$-67.0M
Q2 25
$400.0M
$179.0M
Q1 25
$-57.0M
$-270.0M
Q4 24
$369.0M
$156.0M
Q3 24
$482.0M
$-112.0M
Q2 24
$279.0M
$827.0M
FCF Margin
GLW
GLW
IEP
IEP
Q1 26
4.5%
Q4 25
14.7%
-18.4%
Q3 25
11.0%
-2.5%
Q2 25
10.4%
7.6%
Q1 25
-1.7%
-14.5%
Q4 24
10.5%
6.1%
Q3 24
14.2%
-4.0%
Q2 24
8.6%
37.6%
Capex Intensity
GLW
GLW
IEP
IEP
Q1 26
8.0%
Q4 25
10.2%
2.8%
Q3 25
8.1%
3.0%
Q2 25
8.0%
4.1%
Q1 25
6.0%
4.7%
Q4 24
7.3%
3.4%
Q3 24
6.4%
2.1%
Q2 24
7.4%
3.0%
Cash Conversion
GLW
GLW
IEP
IEP
Q1 26
0.94×
Q4 25
1.95×
-421.00×
Q3 25
1.82×
0.05×
Q2 25
1.51×
Q1 25
0.96×
Q4 24
2.01×
Q3 24
-2.45×
Q2 24
5.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GLW
GLW

Segment breakdown not available.

IEP
IEP

Public Utilities Inventory Petroleum Products$1.6B61%
Other$381.0M14%
Automotive Services$345.0M13%
Nitrogen Fertilizer Products$131.0M5%
Food Packaging Segment$82.0M3%
Home Fashion Segment$45.0M2%
Renewable Products$32.0M1%
Pharma Segment$23.0M1%
Holding Company$11.0M0%

Related Comparisons